| Sarah J Brinkley, APN | |
|
805 W Centerton Blvd, Centerton, AR 72719-9705 | |
| (479) 224-6368 | |
| (479) 224-6383 |
| Full Name | Sarah J Brinkley |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Adult Health |
| Location | 805 W Centerton Blvd, Centerton, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366776429 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | 2009006906 (Arkansas) | Primary |
| Entity Name | Traci L Ivey |
|---|---|
| Entity Type | Practitioner - Family Practice |
| Entity Identifiers | NPI Number: 1831157858 PECOS PAC ID: 8325006646 Enrollment ID: I20050103000497 |
News Archive
The Lancet published a significant development for TB diagnostics yesterday with concrete and encouraging study outcomes on the effectiveness of the new Xpert MTB/RIF test for TB and rifampicin resistance in realistic health care field conditions. One of the authors, Prof. Mark Nicol of the University of Cape Town (South Africa) who contributed to this study, is an EDCTP Senior Fellow. The article demonstrates that the test can effectively be used in low-resource settings to simplify early and accurate diagnosis of patients. The potential impact is a reduction in the morbidity associated with diagnostic delay, dropout and mistreatment. The article has appeared online on 19 April 2011 and will be published in volume 377 on 30 April 2011.
The House Foreign Affairs Committee on Thursday approved legislation (HR 2829) that would withhold up to half of non-voluntary U.S. contributions to the United Nations "if, in two years, the United Nations is not collecting 80 percent of its regular budget in voluntary contributions," Agence France-Presse reports.
PTC Therapeutics, Inc. (PTC) today announced an exclusive research collaboration and licensing agreement with Roche for the development of orally bioavailable small molecules utilizing PTC's technology called Gene Expression Modulation by Small-molecules (GEMS(TM)).
The U.S. Food and Drug Administration is warning consumers that Stiff Nights, a product marketed as a dietary supplement for sexual enhancement, contains an ingredient that can dangerously lower blood pressure and is illegal.
GOP staff of the House Energy and Commerce and Ways and Means committees released a framework for repealing Medicare's sustainable growth rate formula. One House Democrat said the approach wasn't strong enough.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah J Brinkley, APN 805 W Centerton Blvd, Centerton, AR 72719-9705 Ph: (479) 224-6368 | Sarah J Brinkley, APN 805 W Centerton Blvd, Centerton, AR 72719-9705 Ph: (479) 224-6368 |
News Archive
The Lancet published a significant development for TB diagnostics yesterday with concrete and encouraging study outcomes on the effectiveness of the new Xpert MTB/RIF test for TB and rifampicin resistance in realistic health care field conditions. One of the authors, Prof. Mark Nicol of the University of Cape Town (South Africa) who contributed to this study, is an EDCTP Senior Fellow. The article demonstrates that the test can effectively be used in low-resource settings to simplify early and accurate diagnosis of patients. The potential impact is a reduction in the morbidity associated with diagnostic delay, dropout and mistreatment. The article has appeared online on 19 April 2011 and will be published in volume 377 on 30 April 2011.
The House Foreign Affairs Committee on Thursday approved legislation (HR 2829) that would withhold up to half of non-voluntary U.S. contributions to the United Nations "if, in two years, the United Nations is not collecting 80 percent of its regular budget in voluntary contributions," Agence France-Presse reports.
PTC Therapeutics, Inc. (PTC) today announced an exclusive research collaboration and licensing agreement with Roche for the development of orally bioavailable small molecules utilizing PTC's technology called Gene Expression Modulation by Small-molecules (GEMS(TM)).
The U.S. Food and Drug Administration is warning consumers that Stiff Nights, a product marketed as a dietary supplement for sexual enhancement, contains an ingredient that can dangerously lower blood pressure and is illegal.
GOP staff of the House Energy and Commerce and Ways and Means committees released a framework for repealing Medicare's sustainable growth rate formula. One House Democrat said the approach wasn't strong enough.
› Verified 1 days ago